Evidence map›Paper›PMID 38712935›Full record

ArticleAntimicrobial agents and chemotherapy2024

Analysis of clinical

Sean Bergin, Laura A Doorley, Jeffrey M Rybak, Kenneth H Wolfe, Geraldine Butler, Christina A Cuomo, P David Rogers

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Incidence of azole resistance among clinical isolates ofNew microbes and new infections · 2026
    Article
  6. Article
  7. Article
  8. Catechin Augments the Antifungal Efficacy of Fluconazole AgainstInternational journal of molecular sciences · 2026
    Article
  9. Six-month surveillance ofFrontiers in cellular and infection microbiology · 2026
    Article
  10. Review
  11. Small pangenome ofmBio · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Sean BerginSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.ORCID 0000-0002-1034-8938
Laura A DoorleyDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Jeffrey M RybakDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Kenneth H WolfeSchool of Medicine, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.ORCID 0000-0003-4992-4979
Geraldine ButlerSchool of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Belfield, Dublin, Ireland.ORCID 0000-0002-1770-5301
Christina A CuomoInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.ORCID 0000-0002-5778-960X
P David RogersDepartment of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.ORCID 0000-0002-4401-0679

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
Viral Genomics: evolution, spread, and host interactionsU19AI110818 · NIAID · BROAD INSTITUTE, INC. · PI EARL, ASHLEE MIRIAM · 2014 to 2024
$66.5M
Novel Azole Resistance Mechanisms in Candida albicansR01AI058145 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ROGERS, P. DAVID · 2005 to 2021
$5.8M
Novel Azole Resistance Mechanisms in Candida albicansR21AI058145 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ROGERS, P DAVID · 2004 to 2004
$292k
EC | European Research Council (ERC) 789341HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) A1058145HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI110818NCI NIH HHS P30 CA021765NIAID NIH HHS U19 AI110818Science Foundation Ireland (SFI) 18/CRT/6214Science Foundation Ireland (SFI) 19/FFP/6668Science Foundation Ireland (SFI) 20/FFP-A/8795
6 · The paper itself

Abstract

We used whole-genome sequencing to analyze a collection of 35 fluconazole-resistant and 7 susceptible

Indexed as

Antifungal AgentsCandida parapsilosisDNA Copy Number VariationsDrug Resistance, FungalFluconazoleMicrobial Sensitivity TestsCandidiasisFungal ProteinsHumansPhylogenyWhole Genome SequencingAntifungal AgentsFluconazoleFungal ProteinsazolesCNVdrug resistance mechanismsgenomicsyeasts

Identifiers

PMID38712935
PMCPMC11620501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.